{
    "2018-04-02": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Abbott Starts GUIDE-HF Clinical Trial for CardioMEMS Device",
                "features": {
                    "keywords": [
                        "Abbott",
                        "GUIDE-HF",
                        "Clinical Trial",
                        "CardioMEMS"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "How Eli Lilly’s Cardiovascular Products Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Cardiovascular Products",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Analysts’ Recommendations for Bristol-Myers Squibb in March 2018",
                "features": {
                    "keywords": [
                        "Analysts’ Recommendations",
                        "Bristol-Myers Squibb",
                        "March 2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}